BRCA1 and breast carcinoma: Differences in gene expression levels between cancer and non-cancer samples, as well as between the HN and CN, were consistent with the already known hallmarks of cancer, in particular for breast cancer, such as the activity via estrogen or BRCA1 signalling pathways (Fig. 7).